Due Diligence
Our TRN team of consultants are able to offer:
- Scientific review of non-clinical data packages (Pharmacology, Toxicology, ADME, CMC) for potential in-licensing of candidate drugs
- Evaluation of the completeness of the data package
- Evaluation of the studies performed for regulatory compliance
- Critical assessment of any findings that may impact further development or regulatory compliance
- Assessment of the relevance of findings to human safety
- Strategic advice and guidance on additional studies to address findings or mitigate against the possibility of regulatory delays
- See our due diligence flyer
